15 Mai 2016 Jahr - Daily treatment with Vismodegib (Hh
antagonist) downregulated Hh target
genes Gli1, Hhip and Ptch1 and caused
significant reduction of tumour volume
and tumour growth delay.
Beschreibung:
Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growth In Vivo by Affecting Stroma.
Zugefügt zum Band der Zeit:
Datum: